Featured Abstracts
Review key findings and research highlights presented at major industry conferences and events.
Featured Content
ASTRO 2025
Stereotactic Radiotherapy Boost in Locally Advanced Cervical Carcinoma Patients (STARBACS): Up-to-Date Results of a Phase II, Single Arm, Monoinstitutional Study
ASTRO 2025
Evaluation of Necessary and Sufficient PTV Margins for Offline Adaptive Head and Neck Cases Treated with TomoTherapy
ASTRO 2025
Stereotactic Body Radiation Therapy to Only Prostate and Proximal Seminal Vesicles is a Viable Option for a Favorable Subset of High-Risk Prostate Cancer Patients
Featured Case Studies
Robotic Stereotactic Body Radiation Therapy For High-risk Prostate Cancer: The Georgetown University Experience
This retrospective study examines cancer control and health-related quality of life (HRQOL) outcomes in high-risk prostate cancer patients receiving robotic stereotactic body radiation therapy (SBRT) with Synchrony® real-time adaptive motion management.
Use of Motion Management to Model Unmanaged Motion: Dosimetric Consequences of Unmanaged Prostate Motion Assessed Using Real-time Radiotherapy Adaptation Data
This case report explores the dosimetric impact of unmanaged intrafraction prostate motion during radiotherapy by retrospectively analyzing real-time motion data collected using the Radixact® System with Synchrony®. The study models what would have happened if a patient had been treated without motion management, using deformation vector fields to simulate dose
Stereotactic Body Radiotherapy of a Lung Tumor with Large Respiratory Motion Using Real-time Adaptive Motion Management: A Case Report
Traditional internal target volume (ITV) methods for the treatment of a lung tumor on conventional linac would require a large planning target volume (PTV), risking high radiation exposure to the chest wall and lungs.
899: Prognostic Factors in Extremity Soft Tissue Sarcomas Treated with Radiotherapy
Arthur Lebas et al. | ESTRO | 2025
447: IMRT by TomoTherapy with Concurrent Weekly Cisplatin Followed by Brachytherapy HDR in Locally Advance Cervical Cancer (Prospective Study)
Sofiane Mellouk et al. | ESTRO | 2025
67: Comparative Analysis of 3DCRT, IMRT and Helical TomoTherapy in Glioblastoma: Evaluation of Recurrence Dynamics
Sweekruti Hegde et al. | ESTRO | 2025
3750: Long-term Follow-up Results of Helical TomoTherapy for Non-metastatic Breast Cancer: Single Center Experience
Abdelkarim Uakkas et al. | ESTRO | 2025
3898: One-day Urethral-sparing, HDR-like, Prostate Cancer Robotic SBRT: Preliminary Results of the PRO-FAST Trial
Andrei Fodor et al. | ESTRO | 2025
4009: Film Dosimetry for Surface Irradiation Without Physical Bolus, Calculated in RayStation for Radixact X9
Edwin Rozo et al. | ESTRO | 2025
3802: Clinical Evaluation of Quality Assurance Method Using 4D Moving Phantom for Synchrony’s Lung Tumor Tracking
Koji Sasaki et al. | ESTRO | 2025
4034: Initial Experience and Short-Term Clinical Outcomes of Lung cancer Patients Treated with SBRT Using the Radixact Synchrony Tumor Tracking System
Kadriye Tezcanli et al. | ESTRO | 2025
3734: Analysis and Comparison of CyberKnife MLC Collimator Versus IRIS Collimator in Prostate SBRT
Gaetano Gagliardo et al. | ESTRO | 2025
2226: Impact of Using a Virtual Reality Headset Before Stereotactic Radiotherapy Sessions with CyberKnife®
Ilan Darmon et al. | ESTRO | 2025
3355: Development and Validation of a Knowledge-Based Model for Automated CyberKnife Planning in Brain Lesions
Rita C. Buono et al. | ESTRO | 2025
2302: Correlation of Lung Tumor Motion with Clinical Covariates: A Retrospective Evaluation of CyberKnife Synchrony Data
Ashlesha Gill et al. | ESTRO | 2025
